Related Experiment Video
Updated: Feb 16, 2026

05:12
Author Spotlight: AQRNA-seq Role in Mapping Small RNAs and Unraveling Protein Translation Mechanisms
Published on: February 2, 2024
1.4K
The transcriptome of Mycobacterium tuberculosis in a lipid-rich dormancy model through RNAseq analysis
Diana A Aguilar-Ayala1,2, Laurentijn Tilleman3, Filip Van Nieuwerburgh3
1Laboratory of Microbiology, Faculty of Science, Ghent University, Gent, Belgium. di_angel_5@hotmail.com.
Scientific Reports
|December 17, 2017
Summary
This study reveals how Mycobacterium tuberculosis (Mtb) gene expression changes in lipid-rich environments, identifying key pathways for drug tolerance and persistence in tuberculosis (TB) infections.
Area of Science:
- Microbiology
- Molecular Biology
- Infectious Diseases
Background:
- Tuberculosis (TB) remains a leading global infectious killer.
- Lipids are crucial during Mycobacterium tuberculosis (Mtb) infection, but Mtb's transcriptome in lipid-rich environments is poorly understood.
- Current research often overlooks Mtb's metabolic state during pathogenesis.
Purpose of the Study:
- To investigate the transcriptional response of Mtb H37Rv in a lipid-rich environment (cholesterol and fatty acids).
- To analyze gene expression under both aerobic and hypoxic conditions.
- To identify genes and pathways involved in Mtb's adaptation and survival.
Main Methods:
- RNA sequencing (RNAseq) was employed to determine the transcriptome of Mtb H37Rv.
- Experiments were conducted in a lipid-rich medium containing cholesterol and fatty acids.
- Gene expression was analyzed under both aerobic and hypoxic conditions.
Main Results:
- Lipid-rich conditions significantly induced the expression of 368 genes in Mtb.
- A core lipid response was identified, involving efflux systems, iron, and sulfur metabolism.
- Gene expression patterns suggest a role in preparing Mtb for drug tolerance and persistence.
Conclusions:
- Understanding Mtb's lipid metabolism and transcriptional response is vital for TB control.
- Identified pathways could be targeted for developing new anti-TB drugs and vaccines.
- Findings contribute to strategies for managing persistent and drug-tolerant TB populations.

